TOMASZ WOLOSZYN: Open Payments
NPI 1811284714 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,535 in 135 payments from 27 companies in 2025. Trend: 2023 $4,472 · 2024 $3,423 · 2025 $2,535
Food & beverage: $2,535
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $554 |
| Lilly USA, LLC | 12 | $241 |
| PFIZER INC. | 12 | $207 |
| Novo Nordisk Inc | 9 | $166 |
| ABBVIE INC. | 12 | $150 |
| Exact Sciences Corporation | 7 | $143 |
| GlaxoSmithKline, LLC. | 16 | $138 |
| Lundbeck LLC | 4 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $76 |
Products named: AIRSUPRA, FARXIGA, REXULTI, JARDIANCE, NURTEC ODT, TRELEGY ELLIPTA, VRAYLAR, MOUNJARO.
Industry payments across NY — which companies pay providers there.
